Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02268916 · ClinicalTrials.gov registry record · NA

Physical Activity and Participation

A NA study of Type 2 Diabetes Mellitus, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
104
Enrollment target
1
Study location

NCT02268916: Completed NA study of Type 2 Diabetes Mellitus, sponsored by VA Office of Research and Development.

NCT02268916 is a NA study of Type 2 Diabetes Mellitus that has completed, run by VA Office of Research and Development. The registered enrollment target is 104 participants, below the 2,959-participant average among 130 other Type 2 Diabetes Mellitus trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02268916, a NA study of Type 2 Diabetes Mellitus, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
104 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to investigate if the investigators can improve physical activity and social participation level among Veterans with diabetes.

Primary Outcome

Home physical activity changes from baseline to 6-months.Physical activity was measured using a validated survey called CHAMPS, asking the participants to report activities that they participated in a typical week, such as walking, doing house work, dancing, etc.

Conditions Studied

Interventions

  • BEHAVIORAL Counseling
  • BEHAVIORAL Usual education

Study Locations (1)

Michigan

  • VA Ann Arbor Healthcare System, Ann Arbor, MI - Ann Arbor

Trial Details

FieldValue
Enrollment Target 104 participants
Start Date 2015-06-01
Est. Completion 2019-12-31
Phase NA
VA Office of Research and Development

1,668 total trials

What the finished NCT02268916 record still lists

NCT02268916 is an interventional study that assigns participants to a tested intervention. The registered 104 participants enrollment target is mid-sized for trials with a published cap, below the 2,959-participant average among 130 other Type 2 Diabetes Mellitus trials with a reported enrollment target (96% lower).

The record links to 1 condition, with Type 2 Diabetes Mellitus appearing as the primary indexed condition, and to 2 interventions - of which Counseling is the first listed.

NCT02268916 reports a single indexed study location in Michigan.

Frequently Asked Questions

What is clinical trial NCT02268916 about?

NCT02268916 is a clinical study titled "Physical Activity and Participation". The purpose of the study is to investigate if the investigators can improve physical activity and social participation level among Veterans with diabetes.

What is the current status of trial NCT02268916?

This trial is currently completed. It is a NA study. The enrollment target is 104 participants. The study started on 2015-06-01. Estimated completion is 2019-12-31.

What conditions does trial NCT02268916 study?

This clinical trial studies the following conditions: Type 2 Diabetes Mellitus.

What interventions are being tested in trial NCT02268916?

The interventions under investigation include: Counseling (BEHAVIORAL), Usual education (BEHAVIORAL).

Who is sponsoring clinical trial NCT02268916?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02268916 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 2 Diabetes Mellitus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02268916's enrollment target sits among peer trials

104 50th of 130 higher than 81 of 130 other Type 2 Diabetes Mellitus trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Type 2 Diabetes Mellitus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03403686 · 104 participants

    Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)

  • NCT04228367 · 104 participants · NA

    JuggerStitch Post Market Clinical Follow-up Study

  • NCT04268849 · 104 participants · Phase 3

    Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient

  • NCT04390724 · 104 participants

    Optimizing Y90 Therapy for Radiation Lobectomy

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02268916, the US trial registry maintained by the National Library of Medicine. NCT02268916 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.